微生物群
肠道微生物群
生物利用度
药品
计算生物学
疾病
生物
药物开发
药理学
医学
生物信息学
病理
作者
Andrew A. Verdegaal,Andrew L. Goodman
标识
DOI:10.1126/scitranslmed.adg8357
摘要
The gut microbiome harbors trillions of organisms that contribute to human health and disease. These bacteria can also affect the properties of medical drugs used to treat these diseases, and drugs, in turn, can reshape the microbiome. Research addressing interdependent microbiome-host-drug interactions thus has broad impact. In this Review, we discuss these interactions from the perspective of drug bioavailability, absorption, metabolism, excretion, toxicity, and drug-mediated microbiome modulation. We survey approaches that aim to uncover the mechanisms underlying these effects and opportunities to translate this knowledge into new strategies to improve the development, administration, and monitoring of medical drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI